Logo image of QNTM

QUANTUM BIOPHARMA-B SUB VOT (QNTM) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:QNTM - CA74764Y2050 - Common Stock

11.41 USD
+3.37 (+41.92%)
Last: 11/26/2025, 8:00:01 PM
11.9997 USD
+0.59 (+5.17%)
After Hours: 11/26/2025, 8:00:01 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to QNTM. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 32.17. This target is 181.98% above the current price.
QNTM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about QNTM.
In the previous month the buy percentage consensus was at a similar level.
QNTM was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

QNTM Historical Analyst RatingsQNTM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 11.4131.8632.1732.1733.12 - 179.21% 181.98% 181.98% 190.27%

Related screens

QNTM Current Analyst RatingQNTM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

QUANTUM BIOPHARMA-B SUB VOT / QNTM FAQ

Can you provide the average price target for QUANTUM BIOPHARMA-B SUB VOT stock?

7 analysts have analysed QNTM and the average price target is 32.17 USD. This implies a price increase of 181.98% is expected in the next year compared to the current price of 11.41.


What is the consensus rating for QNTM stock?

The consensus rating for QUANTUM BIOPHARMA-B SUB VOT (QNTM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.